Rockville, MD, United States of America

Ronit Mazor

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ronit Mazor

Introduction

Ronit Mazor is a notable inventor based in Rockville, MD (US), recognized for his significant contributions to the field of biotechnology. With a total of four patents to his name, he has made strides in developing innovative solutions for cancer treatment.

Latest Patents

Mazor's latest patents include advancements in exotoxin A with reduced immunogenic T cell and/or B cell epitopes. This invention provides exotoxin A (PE) comprising an amino acid sequence that includes substitutions of one or more B-cell and/or T-cell epitopes. The invention also encompasses related chimeric molecules, nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions. Furthermore, it outlines methods for treating or preventing cancer in mammals, inhibiting the growth of target cells, and producing both the PE and the chimeric molecule.

Career Highlights

Throughout his career, Ronit Mazor has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Hoffmann-La Roche Inc. His work in these institutions has contributed to the advancement of medical research and therapeutic development.

Collaborations

Mazor has collaborated with esteemed colleagues such as Ira H. Pastan and Masanori Onda, further enhancing the impact of his research and innovations.

Conclusion

Ronit Mazor's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in medical science and therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…